Get access to Glenmark information and resources for stories in development.
Find recent and archived press releases.
Glenmark receives ANDA approval for Potassium Chloride Extended-Release Tablets USP, 10 mEq & 20 mEq
August 8, 2016
Glenmark Pharmaceuticals receives ANDA approval for Potassium Chloride Extended-Release Tablets USP, 10 mEq & 20 mEq
July 27, 2016
July 25, 2016
Search Result :-Is an investigational new drug that has not been approved for commercial distribution in the United States.
US Media Contact
For media inquiries only, please contact An Phan, Corporate Communications.
For more information on Glenmark Pharmaceuticals Ltd., including Annual Reports, Analyst Presentations and Financial Results, please visit our Investor Relations.